CIK 0001678660
- Non-accelerated filer
- Smaller reporting company
Prelude Therapeutics Inc
Sign in to watch- Ticker
- PRLD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 811384762
- Phone
- +1 302-467-1280
- Business address
- 175 INNOVATION BOULEVARD, WILMINGTON, DE, 19805
- Former names
- Prelude Therapeutics Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-04 | Combs Andrew Chief Chemistry Officer | Grant or award · Employee Stock Option (right to buy) | +230,000 | 230,000 | ||
| 2025-03-25 | Combs Andrew Chief Chemistry Officer | Purchase | +100,000 | $0.69 | $69K | 480,123 |
| 2025-02-04 | Combs Andrew Chief Chemistry Officer | Grant or award · Employee Stock Option (right to buy) | +175,000 | 175,000 | ||
| 2024-12-23 | Combs Andrew Chief Chemistry Officer | Purchase | +60,000 | $1.37 | $82K | 377,623 |
| 2024-12-20 | Combs Andrew Chief Chemistry Officer | Purchase | +3,075 | $1.15 | $4K | 317,623 |
| 2024-03-01 | Combs Andrew Chief Chemistry Officer | Grant or award · Employee Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2023-02-07 | Combs Andrew EVP, Head of Chemistry | Grant or award · Employee Stock Option (right to buy) | +135,000 | 135,000 | ||
| 2022-04-01 | Combs Andrew EVP, Head of Chemistry | Exercise or conversion · Employee Stock Option (right to buy) | −36,062 | 50,397 | ||
| 2022-03-31 | Combs Andrew EVP, Head of Chemistry | Exercise or conversion | +36,062 | $1.89 | $68K | 304,442 |
| 2022-02-15 | Combs Andrew EVP, Head of Chemistry | Grant or award · Employee Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2021-12-14 | Combs Andrew EVP, Head of Chemistry | Purchase | +4,000 | $11.60 | $46K | 268,380 |
| 2021-12-13 | Combs Andrew EVP, Head of Chemistry | Purchase | +4,000 | $12.12 | $48K | 264,380 |
| 2021-07-20 | Combs Andrew EVP, Head of Chemistry | Grant or award · Employee Stock Option (Right to Buy) | +95,000 | 95,000 | ||
| 2020-09-29 | Combs Andrew EVP, Head of Chemistry | Purchase | +1,000 | $19.00 | $19K | 260,380 |
Page 1 of 1 · 14 trades